Efficacy Of GSK’s Lamictal In Grand Mal Seizures Demonstrated In Pediatrics Study
This article was originally published in The Pink Sheet Daily
Executive Summary
The anti-epileptic lamotrigine is not currently indicated for the treatment of primary generalized tonic-clonic seizures.
You may also be interested in...
GSK’s Lamictal Adds Indication As Add-On Therapy For Grand Mal Seizures
Next in the pipeline for GSK’s epilepsy franchise is an XR formulation for once-daily dosing.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.